Research graph
References from Clinical and Metabolic Predictors of Abnormal Uterine Bleeding in Women With Type 2 Diabetes Mellitus: A Retrospective Cohort Study. Local targets link to admitted publications; unresolved targets remain external evidence.
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
10.1002/ijgo.12666 · 2018 · External reference
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
10.1038/s41574-021-00629-4 · 2022 · External reference
Abnormal uterine bleeding
10.1016/j.mcna.2022.10.014 · 2023 · External reference
Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2
10.1002/ijgo.14946 · 2023 · External reference
Therapeutic options for the management of abnormal uterine bleeding
10.1002/ijgo.14947 · 2023 · External reference
Abnormal uterine bleeding in reproductive age women: role of imaging in the diagnosis and management
10.1053/j.sult.2023.10.002 · 2023 · External reference
Management of women with abnormal uterine bleeding: clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)
10.1016/j.ejogrb.2023.07.001 · 2023 · External reference
Therapeutic carbohydrate restriction as a metabolic modality for the prevention and treatment of abnormal uterine bleeding
10.3390/nu15173760 · 2023 · External reference
Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction
10.1080/09513590.2024.2362244 · 2024 · External reference
Diagnosis of abnormal uterine bleeding based on the FIGO classification: a systematic review and expert opinions
10.1111/jog.16073 · 2024 · External reference
The uterus is an end organ: a preliminary study of the association between abnormal uterine bleeding and hyperinsulinemia
10.1097/gme.0000000000002548 · 2025 · External reference
Menstrual irregularities and cardiometabolic risk: a systematic review and meta-analysis
10.1016/j.ejogrb.2025.114796 · 2026 · External reference
Polycystic ovary syndrome as a metabolic disease
10.1038/s41574-024-01057-w · 2025 · External reference
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
10.1186/s13048-022-01091-0 · 2023 · External reference
Hormonal changes in PCOS
10.1530/joe-23-0342 · 2024 · External reference
The interplay of uterine health and obesity: a comprehensive review
10.3390/biomedicines12122801 · 2024 · External reference
Female obesity: association with endocrine disruption and reproductive dysfunction
10.1016/j.obmed.2021.100375 · 2021 · External reference
Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review
10.1016/j.ejogrb.2023.06.028 · 2023 · External reference
Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
10.1016/j.biopha.2020.110764 · 2020 · External reference
Metformin for endometrial hyperplasia
10.1002/14651858.cd012214.pub3 · 2024 · External reference
Metformin for endometrial hyperplasia
10.1002/14651858.cd012214.pub3 · ExternalCitation · doi-reference
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
10.1002/ijgo.12666 · ExternalCitation · doi-reference
Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2
10.1002/ijgo.14946 · ExternalCitation · doi-reference
Therapeutic options for the management of abnormal uterine bleeding
10.1002/ijgo.14947 · ExternalCitation · doi-reference
Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
10.1016/j.biopha.2020.110764 · ExternalCitation · doi-reference
Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review
10.1016/j.ejogrb.2023.06.028 · ExternalCitation · doi-reference
Management of women with abnormal uterine bleeding: clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)
10.1016/j.ejogrb.2023.07.001 · ExternalCitation · doi-reference
Menstrual irregularities and cardiometabolic risk: a systematic review and meta-analysis
10.1016/j.ejogrb.2025.114796 · ExternalCitation · doi-reference
Abnormal uterine bleeding
10.1016/j.mcna.2022.10.014 · ExternalCitation · doi-reference
Female obesity: association with endocrine disruption and reproductive dysfunction
10.1016/j.obmed.2021.100375 · ExternalCitation · doi-reference
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
10.1038/s41574-021-00629-4 · ExternalCitation · doi-reference
Polycystic ovary syndrome as a metabolic disease
10.1038/s41574-024-01057-w · ExternalCitation · doi-reference
Abnormal uterine bleeding in reproductive age women: role of imaging in the diagnosis and management
10.1053/j.sult.2023.10.002 · ExternalCitation · doi-reference
Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction
10.1080/09513590.2024.2362244 · ExternalCitation · doi-reference
The uterus is an end organ: a preliminary study of the association between abnormal uterine bleeding and hyperinsulinemia
10.1097/gme.0000000000002548 · ExternalCitation · doi-reference
Diagnosis of abnormal uterine bleeding based on the FIGO classification: a systematic review and expert opinions
10.1111/jog.16073 · ExternalCitation · doi-reference
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
10.1186/s13048-022-01091-0 · ExternalCitation · doi-reference
Hormonal changes in PCOS
10.1530/joe-23-0342 · ExternalCitation · doi-reference
The interplay of uterine health and obesity: a comprehensive review
10.3390/biomedicines12122801 · ExternalCitation · doi-reference
Therapeutic carbohydrate restriction as a metabolic modality for the prevention and treatment of abnormal uterine bleeding
10.3390/nu15173760 · ExternalCitation · doi-reference
